Tropisetron
ALIMENTARY TRACT AND METABOLISM
Also known as: navoban, tropisetron HCl, tropisetron hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Tropisetron is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1992. DrugCentral lists 21 molecular targets, including Htr3a|Htr3b, HTR3B and HTR3A. Recorded indications include Chemotherapy-induced nausea and vomiting.
- Molecular targets: Htr3a|Htr3b, HTR3B, HTR3A and Htr3a|Htr3b (21 listed in DrugCentral).
- Indications: Chemotherapy-induced nausea and vomiting.
- ATC code: A04AA03 (Serotonin (5HT3) antagonists).
- Molecular formula: C17H20N2O2; molecular weight 284.36 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Chemotherapy-induced nausea and vomiting
Mechanism & targets
Molecular targets (21)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Serotonin 3 (5-HT3) receptor | Htr3a|Htr3b | unknown | Ki 8.89 |
| 5-hydroxytryptamine receptor 3B | HTR3B | unknown | Ki 8.80 |
| 5-hydroxytryptamine receptor 3A | HTR3A | antagonist | Ki 8.80 |
| Serotonin 3 receptor (5HT3) | Htr3a|Htr3b | unknown | Ki 8.42 |
| 5-hydroxytryptamine receptor 1A | HTR1A | unknown | Ki 8.28 |
| Neuronal acetylcholine receptor subunit alpha-7 | CHRNA7 | unknown | Ki 8.16 |
| Neuronal acetylcholine receptor subunit alpha-7 | Chrna7 | unknown | Ki 8.16 |
| Neuronal acetylcholine receptor subunit alpha-7 | Chrna7 | unknown | EC50 8.00 |
| 5-hydroxytryptamine receptor 3A | HTR3A | unknown | Kd 7.52 |
| 5-hydroxytryptamine receptor 4 | Htr4 | unknown | Ki 7.20 |
| 5-hydroxytryptamine receptor 4 | Htr4 | antagonist | Ki 7.10 |
| 5-hydroxytryptamine receptor 4 | HTR4 | unknown | Ki 6.90 |
| 5-hydroxytryptamine receptor 4 | HTR4 | unknown | Ki 6.85 |
| Sodium-dependent serotonin transporter | SLC6A4 | unknown | Ki 6.59 |
| Muscarinic acetylcholine receptor M5 | CHRM5 | unknown | Ki 5.61 |
| Glycine receptor subunit beta | GLRB | antagonist | Ki 5.30 |
| Glycine receptor subunit alpha-2 | GLRA2 | antagonist | Ki 4.90 |
| Neuronal acetylcholine receptor subunit alpha-3 | CHRNA3 | unknown | Ki 4.80 |
| Acetylcholine receptor; alpha1/beta1/delta/gamma | CHRNA1|CHRNG|CHRNB1|CHRND | unknown | Ki 4.57 |
| Neuronal acetylcholine receptor; alpha4/beta2 | CHRNB2|CHRNA4 | unknown | Ki 4.26 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1992-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
A04AA03 | ALIMENTARY TRACT AND METABOLISM › ANTIEMETICS AND ANTINAUSEANTS › ANTIEMETICS AND ANTINAUSEANTS › Serotonin (5HT3) antagonists |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Myelosuppression | 217.6 |
| White blood cell count decreased | 205.6 |
| Neutrophil count decreased | 176.3 |
| Platelet count decreased | 169.5 |
| Bone marrow failure | 149.6 |
| Lymphocyte count decreased | 81.7 |
| Hepatic function abnormal | 72.9 |
| Vomiting | 68.1 |
| Hypokalaemia | 64.5 |
| Hepatotoxicity | 59.8 |
| Hypocalcaemia | 55.7 |
| Nausea | 53.1 |
Chemical structure
| Molecular formula | C17H20N2O2 |
|---|---|
| Molecular weight | 284.36 g/mol |
| CAS number | 89565-68-4 |
| InChIKey | ZNRGQMMCGHDTEI-ITGUQSILSA-N |
| PubChem CID | 656665 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Tropisetron used for?
DrugCentral lists the following indications for Tropisetron: Chemotherapy-induced nausea and vomiting.
How does Tropisetron work?
Its molecular targets in DrugCentral include Htr3a|Htr3b, HTR3B, HTR3A (antagonist) and Htr3a|Htr3b.
When was Tropisetron first approved?
Tropisetron was first approved by the YEAR INTRODUCED in 1992.
What is the chemical formula of Tropisetron?
Tropisetron has the molecular formula C17H20N2O2 and a molecular weight of 284.36 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2775 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL56564 — compound record and bioactivity
- PubChem CID 656665 — chemical identifiers
- DrugBank DB11699 — drug record
- FDA UNII 6I819NIK1W — substance identity
- UniProt O95264 (HTR3B) — target protein
- UniProt P46098 (HTR3A) — target protein
- UniProt P08908 (HTR1A) — target protein
- UniProt P36544 (CHRNA7) — target protein
- UniProt Q13639 (HTR4) — target protein
- UniProt P31645 (SLC6A4) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.